Like-for-like sales fell 2.9% and net sales dropped 12.8% year-over-year, mainly due to hyperinflationary effects in Argentina and weak demand in Mexico, but EBITDA margin held at 23.7%. Productivity initiatives and cost controls supported resilience, with growth expected to resume in 1H 2026.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Earlier from Genomma Lab Internacional Sab De Cv Class B
